| 1 | 1 | Andersen, Melisa B. | Targeting RAC1: A Promising therapeutic approach for Triple-Negative Breast Cancer | Biology of Her2/Neu and TNB cancers |
| 1 | 4 | Ariza Bareño, Lizeth Aixa | Norcantharidin: a promising natural compound for the treatment triple negative breast cancer. | Biology of Her2/Neu and TNB cancers |
| 1 | 7 | Barraza de laTorre, Gustavo Adolfo | The Molecular Mechanism of Protein Phosphatase PP2A as a Potential Therapeutic Target to Counteract Metastasis in Breast Cancer | Biology of Her2/Neu and TNB cancers |
| 1 | 10 | Britos, Nicolás | Metronomic chemotherapy in TNBC MDA-MB231 cells exposed to nicotine. Nitric Oxide Synthase participation. | Biology of Her2/Neu and TNB cancers |
| 1 | 13 | Couto, Facundo Luis | INVOLVEMENT OF RUNX1 IN TUMOR HETEROGENEITY ON TNBC CELL LINES | Biology of Her2/Neu and TNB cancers |
| 1 | 16 | Dattilo, Melina Andrea | Insights into Androgen Receptor-Mediated Regulation of Acyl-CoA Synthetase 4 in Breast Cancer | Biology of Her2/Neu and TNB cancers |
| 1 | 19 | Gonzalez, Gonzalo | Thyroid hormones modulate breast cancer metastasis formation by regulating the immune subset distribution in the lungs | Biology of Her2/Neu and TNB cancers |
| 1 | 22 | Pereyra, Laura Lucía | Triple-Negative Breast Cancer: effects of Tamoxifen in the lysosomal pathway | Biology of Her2/Neu and TNB cancers |
| 1 | 25 | Pezzoni, Magdalena | HISTAMINE MODULATES INTRATUMOR MICROBIOTA IN 4T1 TRIPLE NEGATIVE BREAST CANCER | Biology of Her2/Neu and TNB cancers |
| 1 | 28 | Sanchez, Yamila | Metronomic chemotherapy combining paclitaxel and a muscarinic agonist for triple negative breast cancer treatment | Biology of Her2/Neu and TNB cancers |
| 1 | 31 | Toro, Carla Daiana | Targeting ID4 to Reprogram Triple-Negative Breast Cancer for Endocrine Therapy Sensitivity | Biology of Her2/Neu and TNB cancers |
| 1 | 34 | Vivanco, Griselda Micaela | Recovery of specific miRNAs in heparinized plasma obtained from HER2+ breast cancer patients who underwent neoadjuvant therapy protocol. | Biology of Her2/Neu and TNB cancers |
| 1 | 37 | Ambrosio, Luisa | Doxorubicin-loaded sulfonated polyvinyl alcohol microspheres inhibit tumor growth in a murine model of breast cancer. | Biology of luminal breast cancer |
| 1 | 40 | Bogni, Emilia Soledad | IMPACT OF PROMOTER POLYMORPHISM (rs251864) ON ZFP36/TTP TUMOR SUPPRESSOR EXPRESSION IN LUMINAL BREAST CANCER CELLS | Biology of luminal breast cancer |
| 1 | 43 | Coianis, Marcela | ANDROGEN RECEPTORS AND WNT PATHWAY AS THERAPEUTIC TARGETS IN ENDOCRINE RESISTANT BREAST CANCER MODELS | Biology of luminal breast cancer |
| 1 | 46 | de los Santos, Clara | Influence of aging on RET-mediated mammary tumor features and incidence | Biology of luminal breast cancer |
| 1 | 49 | EHRENFELD SLATER, INGRID PAMELA | UNVEILING THE ROLE OF KLK4 AND KLK12 IN THE BREAST CANCER | Biology of luminal breast cancer |
| 1 | 52 | Gutierrez, Maximiliano | FUNCTIONAL ANALYSIS OF GLUCOCORTICOID AND PROGESTERONE RECEPTOR CROSSTALK | Biology of luminal breast cancer |
| 1 | 55 | Mondaca, Joselina | Combination of GnRH Agonist/Antagonist with Protein Kinase Inhibitors Counteracts Growth and Metastasis in Breast Cancer | Biology of luminal breast cancer |
| 1 | 58 | Montani, Mercedes Agustina | TGFβ signaling pathway participates in Heregulin induced luminal breast cancer cell migration | Biology of luminal breast cancer |
| 1 | 61 | Nazer, Ezequiel | Seeking the Truth Behind the Myth: Nuclear Role for Argonaute-1 as an Estrogen-Dependent Enhancer Coactivator | Biology of luminal breast cancer |
| 1 | 64 | Pagnotta, Priscila Ayelén | Metabolic remodeling and the impact of the adipose microenvironment in breast cancer | Biology of luminal breast cancer |
| 1 | 67 | Rodriguez, Maria Sol | Elucidating the role of FGFR2 activation and RUNX2 expression in the progression of luminal breast cancer | Biology of luminal breast cancer |
| 1 | 70 | Saldain, Leo | Invasive mammary carcinomas with different progesterone receptor isoform ratios: metastatic vs. proliferative ability, which is worse? | Biology of luminal breast cancer |
| 1 | 73 | Villagra Delgado, Pedro Joaquín | Effect of CDK2 inhibitors on cell proliferation in an experimental human breast cancer model. | Biology of luminal breast cancer |
| 2 | 2 | Almeida Gouvêa, Celine | Adrenergic receptor expression from public breast cancer databases | Breast Cancer Genomics and Transcriptomics |
| 2 | 5 | Ant, Luciana | Tamoxifen breast cancer treatment modify chromatin lansdcape of endometrial cells | Breast Cancer Genomics and Transcriptomics |
| 2 | 8 | Elia, Andres | Transcriptomic profile of primary luminal breast carcinomas with imbalanced progesterone receptor isoforms expression | Breast Cancer Genomics and Transcriptomics |
| 2 | 11 | Gomez, Laura | Expression and Subcellular Localization of TP73 Isoforms as Prognostic Factors in Breast Cancer Molecular Subtypes | Breast Cancer Genomics and Transcriptomics |
| 2 | 14 | Iungman, Martin | WARNING! Your cell line is just a model. A study of COL1A1 alternative promoters in breast cancer cells. | Breast Cancer Genomics and Transcriptomics |
| 2 | 17 | Lara Montero, Angela | ANALYSIS OF TRISTETRAPOLIN (TTP) BIOLOGICAL ROLE AND TRANSCRIPTIONAL REGULATION IN BREAST CANCER CELLS | Breast Cancer Genomics and Transcriptomics |
| 2 | 20 | Muller Igaz, Lionel | RNA-binding proteins in cancer: exploratory analysis of the neurodegenerative disease-related protein TDP-43 | Breast Cancer Genomics and Transcriptomics |
| 2 | 23 | Olszanowski, Evelyn | The Liver X Receptor interferes with Estrogen Receptor-dependent genomic regulation in MCF7 cells | Breast Cancer Genomics and Transcriptomics |
| 2 | 26 | Ortiz, Ana Laura | UNCOVERING GENE EXPRESSION REGULATION OF R-SPONDIN3, AN ONCOGENE INVOLVED IN BREAST CANCER PROGRESSION | Breast Cancer Genomics and Transcriptomics |
| 2 | 29 | Redondo, Analia Lourdes | GENOMIC PROFILE OF GENETIC VARIANTS ASSOCIATED WITH HEREDITARY BREAST/OVARIAN CANCER: EXPERIENCE FROM THE ANALYSIS OF MULTIGENE PANEL TESTING IN ARGENTINA | Breast Cancer Genomics and Transcriptomics |
| 2 | 32 | Vanderhoeven, Fiorella | Differential Response to All-Trans Retinoic Acid in Breast Cancer Cells: Effects on Metastatic Pathways and Gene Expression | Breast Cancer Genomics and Transcriptomics |
| 2 | 35 | Ariza Bareño, Lizeth | ANALYSIS OF GPC3 EFFECT ON CANCER STEM CELL POPULATIONS | Cancer Stem Cells, Primary Tumor Initiation and Early Metastasis |
| 2 | 38 | Berton, Magalí | The galectin-1-glycan axis in tumour progression and metastasis in breast cancer. | Cancer Stem Cells, Primary Tumor Initiation and Early Metastasis |
| 2 | 41 | Britez Neira, Diego Javier | Lapatinib treatment induces cytotoxic effects on different tumor cell lines and decreases Stemness in triple-negative breast cancer cell lines. | Cancer Stem Cells, Primary Tumor Initiation and Early Metastasis |
| 2 | 44 | Lasagna, Marianela | The agrotoxicant chlorpyrifos increases CSC subpopulation and regulates the expression of CSC markers and molecular targets involved in resistance to antiestrogen therapy | Cancer Stem Cells, Primary Tumor Initiation and Early Metastasis |
| 2 | 47 | SOSA, SOFIA MARIA | RUNX1 TRANSCRIPTIONAL ACTIVITY FAVORS A FINGERPRINT OF DRUG RESISTANCE IN TNBC CELL LINES | Cancer Stem Cells, Primary Tumor Initiation and Early Metastasis |
| 2 | 50 | Balsa, Lucía Mariana | Anticancer activity of novel copper (II) compounds with an acylhydrazone ligands against 2D and 3D human breast cancer models. | Early detection and treatment |
| 2 | 53 | Birocco, Ariadna | Transcriptional factor STAT3 as a potential target for nanoparticle-delivered therapeutics, towards CD44+ breast cancer cells | Early detection and treatment |
| 2 | 56 | Carducci Sartorio, Athina | MIR-28 IMPAIRS PROLIFERATION AND METASTATIC CHARACTERISTICS OF TRIPLE NEGATIVE BREAST CANCER CELLS | Early detection and treatment |
| 2 | 59 | Goldberg, Tatiana Jazmin | Exploring Racemic 5,5-(aryl-alkyl)substituted thiadiazolines as Promising Agents for Treatments of Breast Cancer | Early detection and treatment |
| 2 | 62 | Grinpelc, Agustina | Impact of let-7b-5p on triple negative breast cancer growth and progression. | Early detection and treatment |
| 2 | 65 | Hernandez, Florencia | Design of a platform to rank chemotherapeutic drugs with a multidimensional approach | Early detection and treatment |
| 2 | 68 | Moyano, Ginette | Use of ascitic fluid from patients to evaluate the mechanisms of action of PARP inhibitors | Early detection and treatment |
| 2 | 71 | Nicoud, Melisa | Evaluation of Histamine H3 and H4 Receptors as Prognostic Biomarkers in Triple-Negative Breast Cancer | Early detection and treatment |
| 2 | 74 | Okraine, Yiovana Verónica | The displacement of translesion DNA synthesis polymerases from the replisome sensitize tumor cells to genotoxins | Early detection and treatment |
| 2 | 76 | Santa Maria de la Parra, Lucía | Antiproliferative activity and mechanism of action of novel potent anticancer metallocompound CuHL1 on human TNBC cells | Early detection and treatment |
| 2 | 78 | Vasconcelos Esteves Pinto, Alipio | CYTOTOXIC ACTION OF SHIGA TOXIN IN TRIPLE-NEGATIVE BREAST CANCER: POTENTIAL THERAPEUTIC USE AND INVOLVEMENT OF TDP-43 | Early detection and treatment |
| 3 | 3 | Abramovici Blasco, Ariel Isaac | A novel strategy to kill FANC/BRCA-deficient tumors: depleting cellular glutathione. | Fighting treatment resistance. Immunotherapy |
| 3 | 6 | Bruni, Sofia | Soluble TNF blockade boosts the antitumoral effects of trastuzumab deruxtecan in HER2 positive breast cancer | Fighting treatment resistance. Immunotherapy |
| 3 | 9 | Canzoneri, Romina | Differential expression of regulatory T cells marker genes from peripheral blood of breast cancer patients | Fighting treatment resistance. Immunotherapy |
| 3 | 12 | Mares Ahlers, María Candelaria | Relevance of the correct activation of key mitotic proteins for the survival of cells harboring deficient expression of the BRCA1 and BRCA2 tumor suppressors | Fighting treatment resistance. Immunotherapy |
| 3 | 15 | Ospital, Ignacio | LINS01 HISTAMINE H3 RECEPTOR ANTAGONISTS OVERCOME PLACLITAXEL CHEMORESISTANCE IN 4T1 TRIPLE NEGATIVE BREAST CANCER | Fighting treatment resistance. Immunotherapy |
| 3 | 18 | Rodriguez- Baili, Maria Celeste | Extracellular vesicles derived from TNF-α conditioned macrophages promote endocrine resistance in breast tumor cells | Fighting treatment resistance. Immunotherapy |
| 3 | 21 | Salatino, Mariana | Mifepristone treatment reverts T cell exclusion and immunotherapy resistance programs in hormone-dependent breast luminal tumors | Fighting treatment resistance. Immunotherapy |
| 3 | 27 | Alamino, Vanina Alejandra | Synergistic Antitumor Effects of Metformin and Alpha-Lipoic Acid on Breast Cancer Cell Viability | Metabolism, Signaling and Breast Cancer Risk |
| 3 | 30 | Anselmi Relats, Juan Manuel | In vitro and in vivo effect of the combination of 2’-nitroflavone and safingol in breast cancer | Metabolism, Signaling and Breast Cancer Risk |
| 3 | 33 | BOZTEPE, TUGCE | Boosting Antitumor Action of a Copper(II)-Hydrazone Compound Using Functional Polymer Nanoparticles. | Metabolism, Signaling and Breast Cancer Risk |
| 3 | 36 | Bujan, Sol | EXPOSURE TO ENDOCRINE DISRUPTOR IMIDACLOPRID ENHANCES CELL PROLIFERATION AND MIGRATION IN HER2 POSITIVE BREAST CANCER MODEL | Metabolism, Signaling and Breast Cancer Risk |
| 3 | 39 | Cano, Rocio | THYROXINE PROMOTE MCF-7 CELL VIABILITY VIA GENOMIC PATHWAYS | Metabolism, Signaling and Breast Cancer Risk |
| 3 | 42 | Fernández Chávez, Lucía | GEF-H1 drives breast cancer cells to tumor formation and metastasis | Metabolism, Signaling and Breast Cancer Risk |
| 3 | 45 | Miret, Noelia Victoria | Imidacloprid as a risk factor for breast cancer development | Metabolism, Signaling and Breast Cancer Risk |
| 3 | 48 | Moscoso, Verónica Victoria | WNT5A IS INVOLVED IN THE PRO-TUMORIGENIC ROLE OF GPAT2 EXPRESSION IN MDA CELLS | Metabolism, Signaling and Breast Cancer Risk |
| 3 | 51 | MUÑOZ GARZON, KATHERINE SENETH | Biological activity of two new copper(II)-neocuproine complexes and L-dipeptides (L-Ala-L-Phe) in two breast cancer cell lines. | Metabolism, Signaling and Breast Cancer Risk |
| 3 | 54 | Santa Cruz, Iara Sofía | IN VITRO EFFECT OF NEW HSP90 INHIBITORS ON BREAST CANCER CELLS | Metabolism, Signaling and Breast Cancer Risk |
| 3 | 57 | Santos, Chiara Rita | Effect of neonicotinoid insecticide imidacloprid exposure on breast cancer cells | Metabolism, Signaling and Breast Cancer Risk |
| 3 | 60 | Schweitzer, Karen | HEMEOXIGENASE-1 GENETIC VARIANTS EFFECTS ON BREAST CANCER PROGRESSION | Metabolism, Signaling and Breast Cancer Risk |
| 3 | 63 | Sebik Vasquez, Hassen Nadir | CYTOTOXIC EFFECTS OF NOVEL NAPHTHOQUINONES ON MDA-MB-231 BREAST CANCER CELLS: INDUCTION OF OXIDATIVE STRESS AND APOPTOSIS | Metabolism, Signaling and Breast Cancer Risk |
| 3 | 69 | Aguirre, Paula | Tumoral PD-L1-dependent regulation of TAM immunosuppresion during TNBC progression | Understanding and modeling breast cancer subtypes |
| 3 | 72 | Cardozo, Noelia Paola Natalia | Characterization of Novel M46 Murine Breast Cancer Model | Understanding and modeling breast cancer subtypes |
| 3 | 75 | Fernández, Natalia Brenda | Participation of RUNX1 in mitochondrial dynamics and reprogramming in AR+ TNBC | Understanding and modeling breast cancer subtypes |
| 3 | 77 | Pataccini, Gabriela | Subtyping breast cancer PDX: androgen and glucocorticoid receptors, EGFR and lineage markers | Understanding and modeling breast cancer subtypes |
| 3 | 79 | Real, Sebastián | LEFT-RIGHT EPIGENETIC AND BIOELECTRIC DIFFERENCES IN BREAST CANCER | Understanding and modeling breast cancer subtypes |
| 3 | 80 | Candela Morán Maidana | Studying tumor microenvironment components in breast cancer: association between hyaluronan metabolism and DNA repair mechanisms | Understanding and modeling breast cancer subtypes |
| 3 | 24-A | Carla Torres Orellana | 4HER project: Impact of HER Family Co-Amplifications on Trastuzumab Efficacy and Clinical Outcomes in HER2-Positive Breast Cancer | Fighting treatment resistance. Immunotherapy |
| 3 | 24-B | Johanna Abigail Díaz Albuja | Impact of Thyroid Hormones on Chemotherapy Efficacy in Triple-Negative Breast Cancer Cells via Integrin αvβ3 | Fighting treatment resistance. Immunotherapy |
| 3 | 24-C | Daiana L. Vitale | 4-methylumbelliferone sensitizes breast cancer spheroids to chemotherapeutic treatment with epirubicin: new perspectives for pharmacological repositioning | Fighting treatment resistance. Immunotherapy |
| 3 | 66-A | Erica Daniela Solla | Association between nutrition and tumor microenvironment in breast cancer | Metabolism, Signaling and Breast Cancer Risk |
| 3 | 66-B | Niubys de los Milagros Cayado Gutiérrez | Antitumoral effects of natural derivatives in human breast cancer cells | Metabolism, Signaling and Breast Cancer Risk |
